Spring for a Cure Virtual Gala - Lustgarten Foundation: Pancreatic Cancer Research

Spring for a Cure Virtual Gala

Honoring Dr. Robert F. Vizza

“…and now, onward. We will cure this disease.”
–Dr. Robert F. Vizza

When Dr. Robert F. Vizza started as the Lustgarten Foundation’s first President and CEO, pancreatic cancer was known as an “orphan disease”—a rare but deadly disease with little research into prevention, detection, treatment or an eventual cure. However, through Dr. Vizza’s steadfast leadership, service and dedication, the Lustgarten Foundation has directed nearly $200 million dollars into pancreatic cancer research, forever changing the orphan status and providing hope for thousands of patients, survivors and their families.

Over the past 22 years, Bob has pushed relentlessly to move the science to the clinic. Therefore as part of our Gala, we are naming the Dr. Robert F. Vizza Lustgarten Clinical Accelerator Initiative in Bob’s honor. Funding for the Clinical Accelerator Initiative will allow us to initiate new clinical studies in a way that shortens the time required to move from concept to study launch and to develop smarter clinical trials that improve patient outcomes.

Thank you for recognizing Dr. Vizza’s work and for your continued commitment to putting an end to pancreatic cancer.

Spring for a Cure Digital Journal

Spring for a Cure Virtual Gala

Many Thanks to Our Presenting Sponsors!

Charles F. Dolan

Northwell Health Cancer Institute

The Madison Square Garden Company

Get Involved Today

Get inspired and connect with patients, survivors and loved ones who are all on the same journey.

Back to Top